ArticlebioRxiv : the preprint server for biology2026
Efficient co-transcriptional splicing enforces rapid microexon definition and inclusion by SRRM4.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Alternative splicing expands the coding potential of the genome. Typical human exons are 150 nucleotides long, encoding 50 amino acids. Microexons are only 3-27 nucleotides long; yet they are important regulators of cellular processes in neurons, muscle, and pancreas. In neurons, microexon inclusion is aided by binding of the neuronal splicing factor SRRM4 to flanking upstream 3' splice sites (3'SSs). Whether this manner of exon definition can be achieved in the timeframe of co-transcriptional splicing is unknown. Here, we employed nascent RNA sequencing to analyze SRRM4-dependent microexons in neuronal cells and found that co-transcriptional microexon splicing is so efficient, the upstream intron is removed before the downstream intron is completely synthesized. This suggests a mechanism for microexon inclusion, whereby co-transcriptional removal of the upstream intron eliminates competition for the microexon's non-canonical downstream 5'SS. We found that strengthening this 5'SS promoted constitutive microexon inclusion independently of SRRM4, indicating that SRRM4 binding alone is a strong stimulator of microexon definition. Thus, SRRM4's role is to promote rapid splicing of the upstream intron, leaving the microexon's non-canonical 5'SS as the only option for further splicing. These physiologically significant splicing events thereby require co-transcriptionality to yield neuronal mRNA isoforms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.